Active — Not RecruitingNot Applicable

ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden)

13,000,000 participantsStarted 1965-01-01

Plain-language summary

The ESPRESSO study is a collection of data from all computerised gastrointestinal histopathology reports in Sweden. This allows us to study risk factors for gastrointestinal disease, as well as the prognosis of gastrointestinal disease. A review of the study has been published here: https://pubmed.ncbi.nlm.nih.gov/30679926/

Who can participate

Age range0 Years – 110 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕None

What they're measuring

Incident Mortality [especially rates]

Timeframe: Currently up until 2022

Trial details

NCT IDNCT06371820

SponsorKarolinska Institutet

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2043-05-17

View on ClinicalTrials.gov More Gastrointestinal Diseases trials